US FDA Facility Compliance Actions Could Speed Up Despite Inspections Freeze
Executive Summary
With inspectors no longer out in the field, they have more time to wrap up work on previously completed facility evaluations, attorney Howard Sklamberg says; inspections freeze could delay manufacturers’ abilities to bring facilities into compliance following adverse inspection findings, as well as agency reclassifications of facility status.
You may also be interested in...
US FDA Suspends All Domestic GMP Surveillance Inspections
Agency responds to COVID-19 pandemic's US arrival by suspending domestic surveillance inspections and non-critical for-cause and preapproval inspections.
US FDA Freezes Inspections And Outside Meetings. Will Review Goal Dates Stay Put?
Sponsors have been asked to switch to teleconferences with FDA staff as the agency prepares for more of its employees to work from home.
US FDA Getting Faster At Notifying Drug Facility Owners Of Inspection Status
Agency issued final classification determinations within 90 days after an inspection 86% of the time in fiscal year 2019 and continues to reduce the time interval for sending GMP warning letters, CDER compliance director Donald Ashley tells FDLI conference.